Skip to content

SCHEDULE 13GAccepted Sep 26, 8:18 AM ET

Vor Biopharma Inc. SCHEDULE 13G

Verve Capital Ltd

sec.gov(opens the filing on sec.gov)

Accepted (ET)

8:18 AM

Sep 26, 2025

Filed

Sep 26, 2025

Documents

1

Size

9.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.